Search research articles
Contact Us
Filters
Showing results (51-60 of 57) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 57 results.
Plos One
|
December 24, 2015
The Promise of Intravaginal Rings for Prevention: User Perceptions of Biomechanical Properties and Implications for Prevention Product Development
Kate Morrow Guthrie, Sara Vargas, Julia G Shaw, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 18, 2013
Intravaginal ring eluting tenofovir disoproxil fumarate completely protects macaques from multiple vaginal simian-HIV challenges
James M Smith, Rachna Rastogi, Ryan S Teller, et al.
Antimicrobial Agents and Chemotherapy
|
September 26, 2012
A 90-day tenofovir reservoir intravaginal ring for mucosal HIV prophylaxis
Todd J Johnson, Meredith R Clark, Theodore H Albright, et al.
AIDS (London, England)
|
November 26, 2015
A phase 1 randomized placebo-controlled safety and pharmacokinetic trial of a tenofovir disoproxil fumarate vaginal ring
Marla J Keller, Pedro M Mesquita, Mark A Marzinke, et al.
Antimicrobial Agents and Chemotherapy
|
December 25, 2019
A Subcutaneous Implant of Tenofovir Alafenamide Fumarate Causes Local Inflammation and Tissue Necrosis in Rabbits and Macaques
Jonathan T Su, Solange M Simpson, Samuel Sung, et al.
Plos Pathogens
|
September 23, 2016
Increases in Endogenous or Exogenous Progestins Promote Virus-Target Cell Interactions within the Non-human Primate Female Reproductive Tract
Ann M Carias, Shannon A Allen, Angela J Fought, et al.
Mucosal Immunology
|
March 10, 2016
Enhanced binding of antibodies generated during chronic HIV infection to mucus component MUC16
Bronwyn Gunn, Jeffrey Schneider, Maryam Shansab, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 57) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 57 results.
Plos One
|
December 24, 2015
The Promise of Intravaginal Rings for Prevention: User Perceptions of Biomechanical Properties and Implications for Prevention Product Development
Kate Morrow Guthrie, Sara Vargas, Julia G Shaw, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 18, 2013
Intravaginal ring eluting tenofovir disoproxil fumarate completely protects macaques from multiple vaginal simian-HIV challenges
James M Smith, Rachna Rastogi, Ryan S Teller, et al.
Antimicrobial Agents and Chemotherapy
|
September 26, 2012
A 90-day tenofovir reservoir intravaginal ring for mucosal HIV prophylaxis
Todd J Johnson, Meredith R Clark, Theodore H Albright, et al.
AIDS (London, England)
|
November 26, 2015
A phase 1 randomized placebo-controlled safety and pharmacokinetic trial of a tenofovir disoproxil fumarate vaginal ring
Marla J Keller, Pedro M Mesquita, Mark A Marzinke, et al.
Antimicrobial Agents and Chemotherapy
|
December 25, 2019
A Subcutaneous Implant of Tenofovir Alafenamide Fumarate Causes Local Inflammation and Tissue Necrosis in Rabbits and Macaques
Jonathan T Su, Solange M Simpson, Samuel Sung, et al.
Plos Pathogens
|
September 23, 2016
Increases in Endogenous or Exogenous Progestins Promote Virus-Target Cell Interactions within the Non-human Primate Female Reproductive Tract
Ann M Carias, Shannon A Allen, Angela J Fought, et al.
Mucosal Immunology
|
March 10, 2016
Enhanced binding of antibodies generated during chronic HIV infection to mucus component MUC16
Bronwyn Gunn, Jeffrey Schneider, Maryam Shansab, et al.
Page
of 6